Dr. Francisco Bengoa
EN
Back to the wiki

Soft-tissue tumors

Embryonal rhabdomyosarcoma

Soft tissueMalignant / sarcomaSkeletal muscle tumours

Epidemiology

A subtype of rhabdomyosarcoma in children that, when it involves the musculoskeletal system, can present as a deep mass in a limb or the pelvis. Age, site, and subtype influence the risk group, so the plan is organized with pediatric oncology.

Basic features

It can present as a rapidly growing mass, pain, or functional limitation depending on the anatomical site.

Usual treatment

Pediatric treatment combines chemotherapy, surgery, and radiotherapy tailored to the risk group. Before chemotherapy starts it is worth discussing fertility preservation with the team, because some of these treatments can affect it and the options have to be raised beforehand.

Outcomes and prognosis

The embryonal subtype has a better prognosis than the alveolar subtype, and is generally favorable in localized disease depending on the site, the size, the age, and the response to treatment.

Warning signs

These signs do not necessarily mean cancer, but they warrant evaluation before operating on or needling a mass.

  • A soft-tissue mass that grows, is larger than 5 cm, or is deep.
  • Persistent, night-time or progressive bone pain, especially if it limits activity.
  • A fracture from minimal trauma, or an aggressive bone lesion on an X-ray.
  • A lump that comes back after previous surgery.
  • Neurological symptoms, rapid swelling, or pain associated with a mass.

This information is general and does not replace a medical evaluation. A musculoskeletal tumor must be interpreted together with imaging, physical examination, biopsy when appropriate and each patient's context.

Specialist evaluation

If you have a mass, a bone lesion or a report suggesting a tumor, book an evaluation.

Book an appointment